| Name | [1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene]chloro[3-phenylallyl]palladium(II) 95% |
|---|---|
| Synonyms |
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene]chloro[3-phenylallyl]palladium(II),Pd
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene]chloro[3-phenylallyl]palladium(II), Chlorophenylallyl[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]palladium (II) (4R)-1-{1,3-bis[2,6-bis(propan-2-yl)phenyl]-2,3-dihydro-1H-imidazol-2-ylidene}-4-phenyl-1-palladabicyclo[1.1.0]but-2-en-1-ylium chloride Palladium, [1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene]chloro[(1,2,3-η)-1-phenyl-2-propen-1-yl]-, stereoisomer Chlorophenylallyl[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]palladium (II) Palladium,[1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro Chloro[(1,2,3-n)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) Chloro[(1,2,3-n)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol- 2-ylidene]palladium(II), min ANTI-CONNEXIN 31(C-TERMINAL) antibody produced in rabbit Chloro[(1,2,3-η)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)iMidazol-2-ylidene]palladiuM(II),Min. Chloro[(1,2,3-η)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl) imidazol-2-ylidene]palladium(II), min Phenylallylchloro[1,3-bis(diisopropylphenyl)-2-imidazol-2-ylidene]palladium(II) stereoisomer of [1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene]chloro[(1,2,3-η)-1-phenyl-2-propen-1-yl]palladium [1,3-bis(2,6-di-isopropylphenyl)-4,5-dihydroimidazol-2-ylidene] (3-phenylallyl) chloropalladium(II) )-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) Chloro[(1,2,3-n)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II), min 1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene]chloro[(1,2,3-η)-1-phenyl-2-propen-1-yl]palladium Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)iMidazol-2-ylidene]palladiuM(II),Min PHENYLALLYLCHLORO-[1,3-BIS(DIISOPROPYLPHENYL)IMIDAZOLE-2-YLIDENE]PALLADIUM(II) [1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene](3-phenylallyl) chloropalladium(II) 1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene]chloro[3-phenylallyl]palladium(II) )-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II), min CX 31 Chloro[(1,2,3-n)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II),min. [1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene]chloro[3-phenylallyl]palladium(II) Umicore CX31 Palladium,[1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene]chloro[(1,2,3-h)-(2E)-3-phenyl-2-propen-1-yl]-,stereoisomer Gap junction beta-3 protein GJB3 UMicore CX31, Pd, Product of UMicore [1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene]chloro[3-phenylallyl]palladium(II) (CX 31) PHENYLALLYLCHLORO-[1,3-BIS(DIISOPROPYLPHENYL)IMIDAZOLE-2-YLIDENE]PALLADIUM(II) ISO 9001:2015 REACH |
| Molecular Formula | C36H45ClN2Pd |
|---|---|
| Molecular Weight | 647.62900 |
| Exact Mass | 646.23100 |
| PSA | 9.86000 |
| LogP | 10.84780 |
| Storage condition | -20°C |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H312-H315-H319-H332 |
| Precautionary Statements | P280-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn |
| Risk Phrases | 20/21/22-36/38 |
| Safety Phrases | 22-24/25-26-36/37 |
| RIDADR | NONH for all modes of transport |